How much is Vyvanse? The price of Vyvanse depends entirely on where you live and whether you qualify for government subsidies. In Australia in 2026, Vyvanse costs $25.00 per month on a valid PBS prescription for Medicare card holders — down from $31.60 following the 1 January 2026 PBS co-payment reduction — or $7.70 per month with a concession card. Without PBS subsidy (private prescription), the cost rises to $100–$150+ per month in Australia. In the United States, brand-name Vyvanse retails at approximately $389–$556 per month without insurance, though GoodRx coupons can reduce it to $68–$82 per month for generic lisdexamfetamine.
Australia: The Complete 2026 PBS Price Guide
The January 2026 PBS Co-Payment Reduction
The most important pricing change for Australian Vyvanse patients in 2026 is the federal government’s PBS co-payment reduction, effective 1 January 2026:
- Before 1 January 2026: Maximum PBS co-payment = $31.60 per prescription
- From 1 January 2026: Maximum PBS co-payment = $25.00 per prescription
- This is the lowest PBS co-payment since 2004
- The concession rate remains frozen at $7.70 until at least 2030
- The reduction applies automatically — no application is needed; all PBS-listed Vyvanse prescriptions dispensed from 1 January 2026 use the new rate
The Complete 2026 Australian Vyvanse Price Table
Why Dose Doesn’t Change the PBS Price in Australia
One of the most important and surprising features of Vyvanse pricing under the Australian PBS is that all doses cost the same:
The PBS lists lisdexamfetamine across all approved doses (20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg) at an identical patient co-payment of $25.00 (general) or $7.70 (concession) per 30-capsule pack. The government pays a different amount to the manufacturer depending on dose, but the patient contribution is identical regardless of whether you are on 20 mg or 70 mg.
Practical implication: There is no financial incentive to stay on a lower dose in Australia — your out-of-pocket cost is the same at 70 mg as at 20 mg.
The PBS Safety Net: How to Get Vyvanse Free
The PBS Safety Net is one of the most underutilised features of the Australian healthcare system for patients on regular PBS medications:
How the Safety Net works:Once your cumulative PBS out-of-pocket spending reaches the Safety Net threshold within a calendar year (1 January to 31 December), all further PBS medicines in that year become free (general patients) or remain at the concession rate (concession card holders).
- General patients: $1,748.20 in total PBS co-payments triggers free medicines for the rest of the calendar year
- Concession card holders: $277.20 in total PBS co-payments triggers free medicines for the rest of the calendar year
How quickly you reach the Safety Net on Vyvanse alone:
| Patient Type | Monthly Vyvanse Cost | Months to Safety Net | Month Safety Net Kicks In |
|---|---|---|---|
| General patient | $25.00 | 70 months (5.8 years) — Vyvanse alone | Never on one medication alone |
| General patient (multiple PBS meds) | $25.00 + other meds | Faster with multiple scripts | Varies |
| Concession card holder | $7.70 | 36 months (3 years) — Vyvanse alone | Typically reached if on multiple meds |
Key insight: On Vyvanse alone, general patients will not reach the Safety Net in a single year. However, patients on multiple PBS medications — common for ADHD patients who may also take antidepressants, antihypertensives, or other medications — can accumulate Safety Net spending much faster. All PBS prescriptions in a household count toward the threshold, meaning family members’ medications contribute to a shared Safety Net register.
How to register for the Safety Net:Ask your pharmacy to register all your prescriptions on your PBS Safety Net record — this tracks cumulative spending. You may need to actively request this; it is not always automatic.
Why Your First Vyvanse Script May Cost $100
This is the most common shock experienced by newly diagnosed Australian adults, and it is a specific structural feature of the PBS system:
The private-to-PBS transition issue:The initial Vyvanse prescription from your psychiatrist may be dispensed as a private prescription — particularly if:
- The prescriber has not yet completed the PBS authority paperwork at the initial consultation
- The retrospective childhood diagnosis documentation for the PBS authority has not yet been finalised
- The PBS authority number was not included on the prescription
A private prescription for Vyvanse costs approximately $100 per month at most Australian pharmacies — the unsubsidised price. This is not because PBS doesn’t cover Vyvanse; it is because the specific PBS authority conditions have not yet been satisfied.
How to avoid this:
- Ask your psychiatrist explicitly at the diagnosis consultation: “Will this prescription have PBS authority?”
- Confirm that the retrospective childhood diagnosis documentation has been completed and documented in your clinical record
- If your first script was private, return to your psychiatrist and request a PBS authority prescription — once the clinical requirements are satisfied, you should not continue paying private rates
Australia vs. the World: An International Price Comparison
The difference in Vyvanse pricing between Australia and other countries illustrates the extraordinary value of the PBS subsidy:
The Australian PBS subsidy in dollar terms:The PBS listed price for a 50 mg Vyvanse 30-pack is $46.11 — the government pays the difference between the listed price and your co-payment. At the general rate: government pays $46.11 − $25.00 = $21.11 per month per patient. This subsidy — modest in Australian terms — is enormous by US comparison, where the same medication retails at $389+ without insurance.
USA Pricing: The Full Picture for 2026
For US-based readers (and Australian patients who have used Vyvanse in the US), the American pricing landscape is dramatically different:
Brand-Name Vyvanse (US, 2026)
The retail price of brand-name Vyvanse in the US is essentially identical across all doses — approximately $388–$390 per month regardless of whether you take 10 mg or 70 mg. This has been a consistent pricing feature of brand-name Vyvanse since its US launch.
With a GoodRx coupon, the price drops to:
- 10–40 mg: approximately $68/month
- 50 mg: approximately $76/month
- 60–70 mg: approximately $82/month
Generic Lisdexamfetamine (US, 2026)
Generic lisdexamfetamine became available in the US after Vyvanse’s patent expiry. The introduction of generics has provided some US price relief, though not as dramatically as typical generics:
- Average retail price (generic): approximately $439 per month
- With SingleCare/GoodRx discount at major pharmacies: approximately $63–$91 per month
- With insurance, good coverage: $0–$30 per month for many patients
US Insurance Variability
US out-of-pocket costs vary enormously by insurance plan:
- Excellent insurance (public employee, low deductible): $0–$17/month
- Standard insurance with prior authorisation: $10–$84/month for generic
- High deductible plan, GoodRx coupon: $90–$135/month
- No insurance, brand name: $388–$556/month
- No insurance, generic with best coupon: $63–$91/month
How to Reduce the Cost of Vyvanse in Australia
Strategy 1: Ensure Your Prescription Has PBS Authority (Most Important)
If you are paying more than $25.00 per month, the first question to ask is whether your prescription has PBS authority. Contact your psychiatrist or GP continuation prescriber and confirm the PBS authority number is on the prescription. This single step can reduce your monthly cost from ~$100 to $25 — an annual saving of approximately $900.
Strategy 2: Apply for a Concession Card
If you receive Centrelink payments, hold a Commonwealth Seniors Health Card, Veterans Affairs card, or are a Health Care Card holder, you qualify for the concession rate of $7.70 per month. If you are not sure whether you qualify, contact Services Australia (13 23 00) or check your eligibility online at servicesaustralia.gov.au.
Strategy 3: Register for the PBS Safety Net
Ask your pharmacist to ensure every PBS prescription you collect is registered on your PBS Safety Net record. For patients on multiple medications, the Safety Net threshold may be reachable within a single year, after which medications including Vyvanse become free. Family members in the same household can pool spending toward a shared Safety Net.
Strategy 4: Aboriginal and Torres Strait Islander Patients — Closing the Gap
Aboriginal and Torres Strait Islander patients should register for the Closing the Gap (CTG) PBS co-payment measure at their GP or pharmacy. Under CTG, PBS medications cost:
Strategy 5: Request a 5-Repeat Prescription
PBS Vyvanse prescriptions can be issued with up to 5 repeats — meaning a single prescription covers 6 months of supply. This reduces the number of consultation fees required for prescription renewal and minimises the administrative burden of frequent script collection.
Strategy 6: Compare Pharmacies on Private Prescriptions
If you are temporarily on a private prescription, prices vary between pharmacies — typically ranging from $95 to $150 for a private Vyvanse script. Chemist Warehouse, Priceline, and online pharmacy platforms often offer lower private prices than independent pharmacies for branded medications.
Cost of Getting Diagnosed: The Full Investment Picture
Understanding Vyvanse pricing is incomplete without acknowledging the upfront cost of getting diagnosed in Australia:
The PBS subsidy payback calculation:At $25.00/month versus approximately $100/month private, the PBS subsidy saves approximately $75/month or $900/year. The upfront cost of a private psychiatrist assessment ($600–$1,500) is therefore recouped in PBS savings in approximately 8–20 months — making the initial investment highly worthwhile for long-term patients.
Safety and Important Considerations for Australian Patients
- The 2026 PBS price drop to $25.00 affects every PBS-listed Vyvanse prescription dispensed from 1 January 2026 — if a pharmacy has charged you $31.60 or more after this date, the pricing is incorrect and should be queried
- Concession rates are frozen at $7.70 until 2030 — meaning concession card holders are protected from any future general patient PBS co-payment increases for the next four years
- The PBS Safety Net thresholds in 2026 are $277.20 (concession) and $1,748.20 (general) — track your spending throughout the year using the Medicare app or myGov to identify when you are approaching the threshold
- Private prescription costs vary by pharmacy and dose — always ask for the PBS price first and confirm PBS authority is included before agreeing to a private price
Common Misconceptions About Vyvanse Pricing in Australia
Myth 1: “Vyvanse is expensive in Australia.”Under the PBS, Vyvanse is one of the lowest-cost long-acting stimulants available — $25.00 per month is extraordinarily affordable compared to the US price of $389–$556 per month. The perception of “expensive” in Australia almost always reflects a private prescription scenario, typically because PBS authority conditions have not yet been fully satisfied.
Myth 2: “A higher dose of Vyvanse costs more.”Under the Australian PBS, all doses of Vyvanse (20 mg through 70 mg) cost exactly the same patient co-payment — $25.00 general or $7.70 concession. There is no financial penalty for being on a higher therapeutic dose.
Myth 3: “The PBS doesn’t cover Vyvanse for adults.”Vyvanse was listed on the PBS for adults with ADHD from 1 February 2021. Before that date, Vyvanse was only PBS-listed for children. Adult PBS access requires the retrospective childhood diagnosis documentation, but the coverage itself is now firmly established and has been for over four years.
Myth 4: “Generic Vyvanse is available and cheaper in Australia.”Unlike the US where generic lisdexamfetamine is available, no PBS-listed generic lisdexamfetamine exists in Australia as of mid-2026. The only PBS-listed lisdexamfetamine product in Australia is branded Vyvanse. The equivalent generic cost option in Australia is generic dexamphetamine (5 mg tablets, approximately $12 per 100 at Chemist Warehouse) — a different formulation, but the same active compound at a much lower cost for patients who are suitable for dexamphetamine IR.
How much is Vyvanse Hobart
How much is Vyvanse Devonport
How much is Vyvanse Launceston
How much is Vyvanse Tasmania
How much is Vyvanse Victoria
How much is Vyvanse Queensland
How much is Vyvanse Canberra
How much is Vyvanse Australian Capital Territory
How much is Vyvanse South Australia
How much is Vyvanse New South Wales
How much is Vyvanse Darwin
How much is Vyvanse Ghan
How much is Vyvanse Northern Territory
How much is Vyvanse Australia
How much is Vyvanse Austria
How much is Vyvanse Germany
How much is Vyvanse United Kingdom
How much is Vyvanse Sweden
How much is Vyvanse Denmark
How much is Vyvanse Norway
How much is Vyvanse Finland
How much is Vyvanse Iceland
How much is Vyvanse Netherlands
How much is Vyvanse Spain
How much is Vyvanse Ireland
How much is Vyvanse Switzerland
FAQ: People Also Ask About Vyvanse Cost
How much is Vyvanse per month in Australia in 2026?With a valid PBS prescription, Vyvanse costs $25.00 per month for general Medicare card holders and $7.70 per month for concession card holders — following the 1 January 2026 PBS co-payment reduction. Without PBS subsidy, a private prescription costs approximately $100–$150 per month. All doses (20 mg to 70 mg) cost the same PBS patient co-payment.
Why is my first Vyvanse script so expensive?The most common reason a first Vyvanse script costs approximately $100 is that it is being dispensed as a private prescription without PBS authority. This typically occurs when the PBS retrospective childhood diagnosis documentation has not yet been finalised or when the prescriber has not included the PBS authority number. Contact your prescribing psychiatrist to confirm the PBS authority is in place, and subsequent scripts should be dispensed at the PBS rate.
Is Vyvanse cheaper with a concession card?Yes — significantly. The concession rate for Vyvanse (and all PBS medicines) is $7.70 per month, frozen at this level until at least 2030. If you hold a Pensioner Concession Card, Health Care Card, Commonwealth Seniors Health Card, or Veterans Affairs card, present it every time you collect a PBS prescription to access this rate.
How much is Vyvanse without insurance in the US?Brand-name Vyvanse retails at approximately $389–$556 per month without insurance in the US in 2026, regardless of dose. Using a GoodRx coupon reduces brand-name cost to approximately $68–$82 per month; generic lisdexamfetamine with a discount coupon is available for approximately $63–$91 per month at major US pharmacies. With good insurance coverage, many US patients pay $0–$30 per month.
Is there a generic Vyvanse available in Australia?No — as of mid-2026, branded Vyvanse is the only PBS-listed lisdexamfetamine product in Australia. Generic lisdexamfetamine is available in the US (since Vyvanse’s patent expiry) but has not been listed on the Australian PBS. The closest Australian generic alternative with the same active compound is dexamphetamine IR (generic 5 mg tablets), which is significantly cheaper but provides a different pharmacokinetic profile.
Does the PBS Safety Net apply to Vyvanse?Yes — Vyvanse is a PBS-listed medicine and co-payments toward your monthly Vyvanse scripts count toward the annual PBS Safety Net threshold. In 2026, the thresholds are $1,748.20 for general patients and $277.20 for concession card holders. Once you reach the threshold, Vyvanse (and all other PBS medicines) become free for the remainder of that calendar year. Register all PBS prescriptions with your pharmacy to ensure they count toward your Safety Net record.
